ArticleOncoimmunology2024

Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.

Vincenzo De Falco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.